Literature DB >> 8397126

Reduced motor nerve conduction velocity and Na(+)-K(+)-ATPase activity in rats maintained on L-fucose diet. Reversal by myo-inositol supplementation.

M A Yorek1, T J Wiese, E P Davidson, J A Dunlap, M R Stefani, C E Conner, S A Lattimer, M Kamijo, D A Greene, A A Sima.   

Abstract

L-Fucose is a monosaccharide that occurs in low concentrations in normal serum but has been shown to be increased in diabetic individuals. In cultured mammalian cells, L-fucose is a potent competitive inhibitor of myo-inositol transport. Abnormal myo-inositol metabolism has been proposed to be a factor in the development of diabetic complications. To test the hypothesis that myo-inositol deficiency may be responsible for the electrophysiological and biological defects in diabetic neuropathy, rats were fed a diet containing 10 or 20% L-fucose for a period of 6 wk. After 3 wk, the L-fucose diets in two groups of rats were supplemented with 1% myo-inositol. At the end of the study protocol, motor nerve conduction velocity, sciatic nerve tissue Na(+)-K(+)-ATPase activity, and myo-inositol content were determined. These results were compared with those of STZ-induced diabetic rats fed either a normal diet or a diet containing 1% myo-inositol or with those given 450 mg/kg body wt of sorbinil. Serum L-fucose levels were significantly increased in rats fed a diet containing 10 or 20% L-fucose. In comparison, the serum L-fucose levels in the diabetic rats were increased to a lesser extent. Motor nerve conduction velocity was significantly slower in rats fed a 10 or 20% L-fucose diet. Sciatic nerve composite and ouabain-sensitive Na(+)-K(+)-ATPase activity and myo-inositol content was also significantly decreased. Supplementation of 1% myo-inositol to the L-fucose-containing diet restored nerve myo-inositol levels and significantly improved Na(+)-K(+)-ATPase activity and motor nerve conduction velocity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8397126     DOI: 10.2337/diab.42.10.1401

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction.

Authors:  H Kaneto; J Fujii; T Myint; N Miyazawa; K N Islam; Y Kawasaki; K Suzuki; M Nakamura; H Tatsumi; Y Yamasaki; N Taniguchi
Journal:  Biochem J       Date:  1996-12-15       Impact factor: 3.857

2.  Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.

Authors:  L J Coppey; J S Gellett; E P Davidson; J A Dunlap; D D Lund; D Salvemini; M A Yorek
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

3.  High fructose-induced metabolic changes enhance inflammation in human dendritic cells.

Authors:  N Jaiswal; S Agrawal; A Agrawal
Journal:  Clin Exp Immunol       Date:  2019-04-15       Impact factor: 4.330

4.  Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction.

Authors:  K Terata; L J Coppey; E P Davidson; J A Dunlap; D D Gutterman; M A Yorek
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

5.  Anti-inflammatory effect of AMPK signaling pathway in rat model of diabetic neuropathy.

Authors:  Amin Hasanvand; Hossein Amini-Khoei; Mohammad-Reza Hadian; Alireza Abdollahi; Seyed Mohammad Tavangar; Ahmad Reza Dehpour; Elika Semiei; Shahram Ejtemaei Mehr
Journal:  Inflammopharmacology       Date:  2016-08-09       Impact factor: 4.473

6.  Sodium channels in cultured neuroblastoma cells grown in high glucose or L-fucose.

Authors:  R E Wachtel; S A Kraske; M A Yorek
Journal:  J Membr Biol       Date:  1995-05       Impact factor: 1.843

7.  Trans-synaptic spreading of alpha-synuclein pathology through sensory afferents leads to sensory nerve degeneration and neuropathic pain.

Authors:  Nelson Ferreira; Nádia Pereira Gonçalves; Asad Jan; Nanna Møller Jensen; Amelia van der Laan; Simin Mohseni; Christian Bjerggaard Vægter; Poul Henning Jensen
Journal:  Acta Neuropathol Commun       Date:  2021-02-25       Impact factor: 7.801

Review 8.  Is metformin a possible treatment for diabetic neuropathy?

Authors:  Juechun Wei; Yanling Wei; Meiyan Huang; Peng Wang; Shushan Jia
Journal:  J Diabetes       Date:  2022-09-18       Impact factor: 4.530

9.  Protective effect of Jiaweibugan decoction against diabetic peripheral neuropathy.

Authors:  Yu Wang; Zeqi Chen; Renqun Ye; Yulei He; Yuhong Li; Xinjian Qiu
Journal:  Neural Regen Res       Date:  2013-04-25       Impact factor: 5.135

10.  Insulin Treatment Attenuates Small Nerve Fiber Damage in Rat Model of Type 2 Diabetes.

Authors:  Laura J Andreasen; Rikke K Kirk; Christian Fledelius; Mark A Yorek; Jens Lykkesfeldt; Thorbjorn Akerstrom
Journal:  J Diabetes Res       Date:  2020-08-02       Impact factor: 4.011

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.